OpenAlex
PricingAboutJobs
Log inGet started
Work

A Single-Dose Placebo-Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women

HTML

Year: 2005
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Journal of Bone and Mineral Research
DOI: 10.1359/jbmr.2005.20.12.2274
Authors: Pirow J Bekker, Donna L Holloway, Amy S Rasmussen, Robyn Murphy, Steven W Martin, Philip T Leese, Gregory B Holmes, Colin R Dunstan, Alex M DePaoli
Institutions: Amgen (United States), IQVIA (United States), Anzac Research Institute
Language: English

Topic: Bone health and osteoporosis research
Subfield: Orthopedics and Sports Medicine
Field: Medicine
Domain: Health Sciences
Keywords: postmenopausal women, osteoporosis, bone turnover markers, urinary N-telopeptide, bone-specific alkaline phosphatase, parathyroid hormone, serum calcium, drug safety, dose escalation, subcutaneous administration, osteoclastogenesis, RANKL inhibition, single-dose administration
SDG: Good health and well-being

Open Access status: closed

Funder: Amgen
OpenAlex ID: W4250370139
FWCI: 7.118
Cites: 49
Cited by: 113
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security